20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.5 - Production of medical devices, instruments, and products, including dental products
32.9 - Production of products not classified elsewhere
46 - Wholesale trade
47.75.Z - Retail sale of cosmetics and toiletries
47.91 - Intermediary retail sale, non-specialized
2022 | 2023 | 2024 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 0 | 0 | 0 | 0 |
EBITDA | 66 | |||
Short time liabilities | 46,2 | 46,2 | 46,2 | 0 |
Equity capital | 5 | -32,7 | -32,7 | 0 |
Operating profit (EBIT) | 67,4 | |||
Assets | 13,5 | 13,5 | 13,5 | 0 |
Net profit (loss) | 0 | 0 | 0 | 0 |
Cash | -100 | |||
Liabilities and provisions for liabilities | 46,2 | 46,2 | 46,2 | 0 |
Net income from sale | -100 | |||
Working assets | 13,5 | 13,5 | 13,5 | 0 |
Depreciation | -100 | |||
% | % | % | p.p. | |
Profitability of capital | 0 | 0 | 0 | 0 |
Equity capital to total assets | -71,2 | |||
Gross profit margin | ||||
EBITDA Margin | ||||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 515 | |||
Current financial liquidity indicator | -0,1 | |||
Net dept to EBITDA | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane